Ye Dong, Bramini Mattia, Hristov Delyan R, Wan Sha, Salvati Anna, Åberg Christoffer, Dawson Kenneth A
Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin, Belfield, Dublin 4, Ireland.
present address: AbbVie Deutschland GmbH & Co KG, Brain Delivery at Neuroscience Discovery, Knollstraße, 67061 Ludwigshafen, Germany.
Beilstein J Nanotechnol. 2017 Jul 7;8:1396-1406. doi: 10.3762/bjnano.8.141. eCollection 2017.
Cellular barriers, such as the skin, the lung epithelium or the intestinal epithelium, constitute one of the first obstacles facing nanomedicines or other nanoparticles entering organisms. It is thus important to assess the capacity of nanoparticles to enter and transport across such barriers. In this work, Caco-2 intestinal epithelial cells were used as a well-established model for the intestinal barrier, and the uptake, trafficking and translocation of model silica nanoparticles of different sizes were investigated using a combination of imaging, flow cytometry and transport studies. Compared to typical observations in standard cell lines commonly used for in vitro studies, silica nanoparticle uptake into well-developed Caco-2 cellular barriers was found to be very low. Instead, nanoparticle association to the apical outer membrane was substantial and these particles could easily be misinterpreted as internalised in the absence of imaging. Passage of nanoparticles through the barrier was very limited, suggesting that the low amount of internalised nanoparticles was due to reduced uptake into cells, rather than a considerable transport through them.
细胞屏障,如皮肤、肺上皮或肠上皮,是纳米药物或其他纳米颗粒进入生物体时面临的首要障碍之一。因此,评估纳米颗粒进入并穿过此类屏障的能力非常重要。在这项工作中,Caco-2肠上皮细胞被用作成熟的肠屏障模型,并结合成像、流式细胞术和转运研究,对不同大小的模型二氧化硅纳米颗粒的摄取、运输和转运进行了研究。与体外研究常用的标准细胞系中的典型观察结果相比,发现二氧化硅纳米颗粒在发育良好的Caco-2细胞屏障中的摄取非常低。相反,纳米颗粒与顶端外膜的结合很显著,在没有成像的情况下,这些颗粒很容易被误解为已内化。纳米颗粒通过屏障的过程非常有限,这表明内化纳米颗粒的量低是由于细胞摄取减少,而不是通过细胞的大量运输。